Tuesday, July 30, 2024 3:15:42 PM
manibiotech,
There is a “right time” for management support especially in heavily manipulated stocks or ones that have been. Too early and it means nothing that the manipulators can’t use like an interim pump by traders to bring it back down which then also hurts management and their ability to continue supporting. Too late and lots of smaller but faithful longs get hurt and discouraged to the point of pulling out and this also keeps potential new investors staying on the sidelines longer.
Linda gave an 18 month look which she has never done before. Now it’s time to start backing that up with small steady actions which will help counteract the small steady dilution needed until the good news comes. If the actions by management look anticipatory and unselfish the support will come and nothing needs to be said by them which would be cause for potential litigation. The old saying actions speak louder than words comes to mind here; ). Best wishes.
There is a “right time” for management support especially in heavily manipulated stocks or ones that have been. Too early and it means nothing that the manipulators can’t use like an interim pump by traders to bring it back down which then also hurts management and their ability to continue supporting. Too late and lots of smaller but faithful longs get hurt and discouraged to the point of pulling out and this also keeps potential new investors staying on the sidelines longer.
Linda gave an 18 month look which she has never done before. Now it’s time to start backing that up with small steady actions which will help counteract the small steady dilution needed until the good news comes. If the actions by management look anticipatory and unselfish the support will come and nothing needs to be said by them which would be cause for potential litigation. The old saying actions speak louder than words comes to mind here; ). Best wishes.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
